- Home
- FOXF vs ZLAB Comparison
FOXF vs ZLAB Comparison
Compare FOXF & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FOXF | ZLAB |
|---|---|---|
| Founded | 2007 | 2013 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Motor Vehicles | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 618.2M | 2.0B |
| IPO Year | N/A | 2017 |
Fundamental Metrics
Financial Performance| Metric | FOXF | ZLAB |
|---|---|---|
| Price | $17.49 | $17.61 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 6 |
| Target Price | $33.00 | ★ $57.22 |
| AVG Volume (30 Days) | ★ 992.8K | 856.8K |
| Earning Date | 11-06-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,459,086,000.00 | $441,629,000.00 |
| Revenue This Year | $6.82 | $26.16 |
| Revenue Next Year | $3.76 | $30.62 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 6.22 | ★ 24.14 |
| 52 Week Low | $13.08 | $16.82 |
| 52 Week High | $31.18 | $44.34 |
Technical Indicators
Market Signals| Indicator | FOXF | ZLAB |
|---|---|---|
| Relative Strength Index (RSI) | 52.54 | 34.99 |
| Support Level | $17.41 | $17.50 |
| Resistance Level | $17.86 | $19.01 |
| Average True Range (ATR) | 0.55 | 0.61 |
| MACD | 0.19 | 0.27 |
| Stochastic Oscillator | 72.07 | 35.16 |
Price Performance
Historical ComparisonAbout FOXF Fox Factory Holding Corp.
Fox Factory Holding Corp is a designer, manufacturer, and marketer of performance-defining products and systems used predominantly on bikes, Side-by-Sides, on-road vehicles with and without off-road capabilities, off-road vehicles and trucks, ATVs, snowmobiles, specialty vehicles and applications, motorcycles, and commercial trucks. Its business operates under the FOX, FOX RACING SHOX, and RACE FACE brands. Geographically, it derives a majority of revenue from North America and also has a presence in Asia, Europe, and the Rest of the World.
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.